SE0303270D0 - Method for administration of tiotropium - Google Patents

Method for administration of tiotropium

Info

Publication number
SE0303270D0
SE0303270D0 SE0303270A SE0303270A SE0303270D0 SE 0303270 D0 SE0303270 D0 SE 0303270D0 SE 0303270 A SE0303270 A SE 0303270A SE 0303270 A SE0303270 A SE 0303270A SE 0303270 D0 SE0303270 D0 SE 0303270D0
Authority
SE
Sweden
Prior art keywords
dry powder
dose
delivered
inhaler
administration
Prior art date
Application number
SE0303270A
Other languages
English (en)
Other versions
SE0303270L (sv
Inventor
Thomas Nilsson
Mattias Myrman
Sven Calander
Alf Niemi
Original Assignee
Microdrug Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29778163&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE0303270(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Microdrug Ag filed Critical Microdrug Ag
Priority to SE0303270A priority Critical patent/SE0303270L/sv
Publication of SE0303270D0 publication Critical patent/SE0303270D0/sv
Priority to US10/729,024 priority patent/US20050121026A1/en
Priority to AT04801708T priority patent/ATE448776T1/de
Priority to CA002547660A priority patent/CA2547660A1/en
Priority to AU2004294887A priority patent/AU2004294887B2/en
Priority to DE602004024261T priority patent/DE602004024261D1/de
Priority to SI200431340T priority patent/SI1991202T1/sl
Priority to PL04801708T priority patent/PL1991202T3/pl
Priority to ZA200604254A priority patent/ZA200604254B/en
Priority to PT04801708T priority patent/PT1991202E/pt
Priority to PCT/SE2004/001791 priority patent/WO2005053645A1/en
Priority to EP04801708A priority patent/EP1991202B1/en
Priority to ES04801708T priority patent/ES2333725T3/es
Priority to DK04801708.1T priority patent/DK1991202T3/da
Publication of SE0303270L publication Critical patent/SE0303270L/sv
Priority to US11/448,725 priority patent/US20070110678A1/en
Priority to CY20101100009T priority patent/CY1110625T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Otolaryngology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE0303270A 2003-12-03 2003-12-03 Metod för administration av tiotropium SE0303270L (sv)

Priority Applications (16)

Application Number Priority Date Filing Date Title
SE0303270A SE0303270L (sv) 2003-12-03 2003-12-03 Metod för administration av tiotropium
US10/729,024 US20050121026A1 (en) 2003-12-03 2003-12-08 Method for administration of tiotropium
ES04801708T ES2333725T3 (es) 2003-12-03 2004-12-02 Metodo para la administracion de tiotropium.
DK04801708.1T DK1991202T3 (da) 2003-12-03 2004-12-02 Fremgagsmåde til indgivelse af tiotropium
PL04801708T PL1991202T3 (pl) 2003-12-03 2004-12-02 Sposób podawania tiotropium
PT04801708T PT1991202E (pt) 2003-12-03 2004-12-02 Método para administração de tiotrópio
AU2004294887A AU2004294887B2 (en) 2003-12-03 2004-12-02 Method for administration tiotropium
DE602004024261T DE602004024261D1 (de) 2003-12-03 2004-12-02 Verfahren zur verabreichung von tiotropium
SI200431340T SI1991202T1 (sl) 2003-12-03 2004-12-02 Postopek za dajanje tiotropija
AT04801708T ATE448776T1 (de) 2003-12-03 2004-12-02 Verfahren zur verabreichung von tiotropium
ZA200604254A ZA200604254B (en) 2003-12-03 2004-12-02 Method for administration tiotropium
CA002547660A CA2547660A1 (en) 2003-12-03 2004-12-02 Inhalation administration of tiotropium in high amount of metered dose
PCT/SE2004/001791 WO2005053645A1 (en) 2003-12-03 2004-12-02 Method for administration tiotropium
EP04801708A EP1991202B1 (en) 2003-12-03 2004-12-02 Method for administration tiotropium
US11/448,725 US20070110678A1 (en) 2003-12-03 2006-06-08 Method for administration of tiotropium
CY20101100009T CY1110625T1 (el) 2003-12-03 2010-01-05 Μεθοδος για την χορηγηση τιοτροπιου

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0303270A SE0303270L (sv) 2003-12-03 2003-12-03 Metod för administration av tiotropium

Publications (2)

Publication Number Publication Date
SE0303270D0 true SE0303270D0 (sv) 2003-12-03
SE0303270L SE0303270L (sv) 2005-06-04

Family

ID=29778163

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0303270A SE0303270L (sv) 2003-12-03 2003-12-03 Metod för administration av tiotropium

Country Status (15)

Country Link
US (2) US20050121026A1 (sv)
EP (1) EP1991202B1 (sv)
AT (1) ATE448776T1 (sv)
AU (1) AU2004294887B2 (sv)
CA (1) CA2547660A1 (sv)
CY (1) CY1110625T1 (sv)
DE (1) DE602004024261D1 (sv)
DK (1) DK1991202T3 (sv)
ES (1) ES2333725T3 (sv)
PL (1) PL1991202T3 (sv)
PT (1) PT1991202E (sv)
SE (1) SE0303270L (sv)
SI (1) SI1991202T1 (sv)
WO (1) WO2005053645A1 (sv)
ZA (1) ZA200604254B (sv)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL2067779T3 (pl) * 2003-11-03 2013-09-30 Boehringer Ingelheim Int Sole tiotropium, sposoby ich wytwarzania oraz zawierające je kompozycje farmaceutyczne
KR20060102561A (ko) * 2003-11-03 2006-09-27 베링거 인겔하임 인터내셔날 게엠베하 신규한 티오트로피움염, 이의 제조 방법 및 이를 함유하는약제학적 제형
SE0303270L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Metod för administration av tiotropium
SE0303269L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Medicinsk produkt
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
EP1691782A1 (en) * 2003-12-03 2006-08-23 Microdrug AG Medical product containing tiotropium
SE0303571D0 (sv) * 2003-12-03 2003-12-22 Microdrug Ag Medical product for moisture-sensitive medicaments
SE0303569L (sv) * 2003-12-03 2005-06-04 Microdrug Ag DPI för avlämning av fuktkänsliga medikament
TWI274641B (en) * 2005-08-30 2007-03-01 Rexon Ind Corp Ltd Cutting machine
DK2230934T3 (da) 2007-12-14 2012-11-26 Aerodesigns Inc Afgivelse af aerosoliserbare næringsmiddelprodukter
HUE045917T2 (hu) 2009-02-26 2020-01-28 Glaxo Group Ltd 4-{(lR)-2-[(6-(2-[(2,6-Diklórbenzil)-oxi}-etoxi}-hexil)-amino]-l-hidroxietil}-2-(hidroximetil)-fenolt tartalmazó gyógyszerkészítmények
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
LT2435023T (lt) * 2009-05-29 2016-09-26 Pearl Therapeutics, Inc. Kompozicijos, skirtos ilgai veikiančių muskarininių antagonistų ir ilgai veikiančių beta-2-adrenerginio receptoriaus agonistų pristatymui į plaučius, ir susiję būdai bei sistemos
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
WO2014144894A1 (en) 2013-03-15 2014-09-18 Pearl Therapeutics, Inc. Methods and systems for conditioning of particulate crystalline materials
JP6473738B2 (ja) 2013-04-01 2019-02-20 パルマトリックス，インコーポレイテッド チオトロピウム乾燥粉末

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56138200A (en) * 1980-02-15 1981-10-28 Glaxo Group Ltd Androstane carbothioate compound
ATE23272T1 (de) * 1981-07-08 1986-11-15 Draco Ab Pulverinhalator.
ZW21483A1 (en) * 1982-10-08 1985-05-08 Glaxo Group Ltd Device for administering medicaments to patients
ZW6584A1 (en) * 1983-04-18 1985-04-17 Glaxo Group Ltd Phenethanolamine derivatives
US5270305A (en) * 1989-09-08 1993-12-14 Glaxo Group Limited Medicaments
GB9004781D0 (en) * 1990-03-02 1990-04-25 Glaxo Group Ltd Device
US6536427B2 (en) * 1990-03-02 2003-03-25 Glaxo Group Limited Inhalation device
US5785049A (en) * 1994-09-21 1998-07-28 Inhale Therapeutic Systems Method and apparatus for dispersion of dry powder medicaments
US5826633A (en) * 1996-04-26 1998-10-27 Inhale Therapeutic Systems Powder filling systems, apparatus and methods
US20020017295A1 (en) * 2000-07-07 2002-02-14 Weers Jeffry G. Phospholipid-based powders for inhalation
EP1131059B1 (de) * 1998-11-13 2003-03-05 Jago Research Ag Trockenpulver zur inhalation
CA2373278C (en) * 1999-06-05 2011-04-05 Innovata Biomed Limited Medicament delivery device with measuring chamber and dispensing cup
EP1240261B1 (en) * 1999-10-11 2004-02-18 Innovata Biomed Limited Medicament delivery device with moisture resistant coating
SE517806C2 (sv) * 1999-11-11 2002-07-16 Microdrug Ag Doseringsanordning för inhalator
SE9904706D0 (sv) * 1999-12-21 1999-12-21 Astra Ab An inhalation device
PE20011227A1 (es) * 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
GB0009468D0 (en) * 2000-04-17 2000-06-07 Vectura Ltd Improvements in or relating to formulations for use in inhaler devices
GB0015043D0 (en) * 2000-06-21 2000-08-09 Glaxo Group Ltd Medicament dispenser
SE517225C2 (sv) * 2000-09-21 2002-05-14 Microdrug Ag Optimering av en elektrostatiskt doserad inhalator för torrt pulver
DZ3477A1 (sv) * 2000-10-12 2002-04-18
US20030078947A1 (en) * 2001-10-12 2003-04-24 Intel Corporation Methods for assigning unique identifiers in a distributed fault tolerant application
US7258118B2 (en) * 2002-01-24 2007-08-21 Sofotec Gmbh & Co, Kg Pharmaceutical powder cartridge, and inhaler equipped with same
US6591832B1 (en) * 2002-02-21 2003-07-15 Saint-Gobain Calmar Inc. Dry powder dispenser
US20030235538A1 (en) * 2002-04-09 2003-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Method for the administration of an anticholinergic by inhalation
UA80123C2 (en) * 2002-04-09 2007-08-27 Boehringer Ingelheim Pharma Inhalation kit comprising inhalable powder of tiotropium
SE525027C2 (sv) * 2002-04-12 2004-11-16 Microdrug Ag Anordning utgörande en pulverlufthyvel
SE524990C2 (sv) * 2002-04-12 2004-11-09 Microdrug Ag Preparation av terapeutiskt torrt pulver samt förfarande för uppdelning och spridning i luft av medicinskt pulver
SE524957C2 (sv) * 2002-04-12 2004-11-02 Microdrug Ag Förfarande för uppdelning och fördelning i luft av torrt pulvermedikament
GB0225621D0 (en) * 2002-11-02 2002-12-11 Glaxo Group Ltd Medicament carrier
SE0303269L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Medicinsk produkt
SE0303571D0 (sv) * 2003-12-03 2003-12-22 Microdrug Ag Medical product for moisture-sensitive medicaments
SE0303270L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Metod för administration av tiotropium
SE0303570L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
SE0303569L (sv) * 2003-12-03 2005-06-04 Microdrug Ag DPI för avlämning av fuktkänsliga medikament
SE0402345L (sv) * 2004-09-24 2006-03-25 Mederio Ag Uppmätt läkemedelsdos

Also Published As

Publication number Publication date
DE602004024261D1 (de) 2009-12-31
PT1991202E (pt) 2009-12-10
US20050121026A1 (en) 2005-06-09
ZA200604254B (en) 2008-05-28
AU2004294887B2 (en) 2009-12-24
PL1991202T3 (pl) 2010-05-31
SI1991202T1 (sl) 2010-03-31
DK1991202T3 (da) 2010-04-06
EP1991202A1 (en) 2008-11-19
EP1991202B1 (en) 2009-11-18
CA2547660A1 (en) 2005-06-16
ES2333725T3 (es) 2010-02-26
ATE448776T1 (de) 2009-12-15
WO2005053645A1 (en) 2005-06-16
AU2004294887A1 (en) 2005-06-16
US20070110678A1 (en) 2007-05-17
CY1110625T1 (el) 2015-04-29
SE0303270L (sv) 2005-06-04

Similar Documents

Publication Publication Date Title
CY1110625T1 (el) Μεθοδος για την χορηγηση τιοτροπιου
RU2014150422A (ru) Новая дозировка и препаративная форма
ATE400313T1 (de) Verbessertes trockenpulver-inhalationssystem
AR039276A1 (es) Metodo para la administracion de un anticolinergico por inhalacion
RU2014140674A (ru) Новая дозировка и препаративная форма
EE05257B1 (et) K?vade pelletite vormis farmatseutilised preparaadid kuivpulberinhalaatoritele
MY115688A (en) Pharmaceutical composition for administration by inhalation
SE0402976D0 (sv) A medical product
JO2430B1 (en) Pharmaceutical formulas for dry powder inhalations in the form of solid pellets
ZA200604616B (en) Inhalable tiotropium and container therefor
US7431916B2 (en) Administration of medicinal dry powders
SE0303091D0 (sv) Combined doses of tiotropium andfluticasone
AU2014261539A1 (en) Inhalable pharmaceutical compositions and the inhaler devices containing them
KR101659741B1 (ko) 분말약 마우스피스 컨테이너 및 그 응용
US20040258624A1 (en) Combined doses